Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Anastasios Giannou (Patras, Greece), Anastasios D. Giannou, Antonia Marazioti, Magda Spella, Hara Apostolopoulou, Nikolaos I. Kanellakis, Ioannis Psallidas, Malamati Vreka, Dimitra E. Zazara, Ioannis Lilis, Theodora Agalioti, Georgios T. Stathopoulos. LSC Abstract – A requirement for mast cells in malignant pleural effusion. Eur Respir J 2015; 46: Suppl. 59, 4354

Member's Comments

No comment yet.

Related content which might interest you: Mast cells recruitment to malignant pleural effusions Source: Annual Congress 2010 - Current issues in malignant pleural diseases Year: 2010 Utility of significant number of mesothelial cells in tuberculous pleural effusions Source: Eur Respir J 2004; 24: Suppl. 48, 426s Year: 2004 Malignant pleural effusion cells show aberrant glucose metabolism gene expression Source: Eur Respir J 2011; 37: 1453-1465 Year: 2011 The value of IL6 in differentiation between malignant and non malignant pleural effusion Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience Year: 2009 LSC Abstract – Host-environmental IL-1b drives mutant KRAS-IKKa addiction in malignant pleural effusion Source: International Congress 2016 – New genomic targets in pulmonary disease Year: 2016 Biological characteristics of dendritic cells from malignant pleural effusions in patients with lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 772s Year: 2006 Separating malignant from nonmalignant pleural effusion on the basis of PO2 in pleural effusion Source: Eur Respir J 2003; 22: Suppl. 45, 541s Year: 2003 Pleurodesis for malignant pleural effusion Source: ERS Course 2016 - Skills course on medical thoracoscopy Year: 2016 Pleurodesis for malignant pleural effusion Source: School Course 2014 - Medical Thoracoscopy Year: 2014 Transudative malignant pleural effusions Source: International Congress 2019 – Novel approaches to pleural effusion: should I change my practice? Year: 2019 Talc mediates angiostasis in malignant pleural effusions via endostatin induction Source: Eur Respir J 2007; 29: 761-769 Year: 2007 Clinical role of pleural effusion MMP-3 levels in malignant pleural mesothelioma Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions Year: 2012 CD8+ lymphocyte subpopulations in pleural fluid are associated with longer survival in patients with malignant pleural effusion (MPE) submitted to thoracoscopic talc pleurodesis Source: Eur Respir J 2002; 20: Suppl. 38, 70s Year: 2002 Management of malignant pleural effusion Source: Eur Respir J 2001; 18: Suppl. 33, 397s Year: 2001 Pleurodesis in the treatment of malignant pleural effusion Source: Eur Respir J 2004; 24: Suppl. 48, 628s Year: 2004 Correlation between pleural fluid cytological yield and pleural tumour burden in malignant pleural effusions Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement? Year: 2010 Management of malignant pleural effusions Source: Eur Respir J 2001; 18: 402-419 Year: 2001 Management of malignant pleural effusions Source: ERS Skills course: Multi-disciplinary care in thoracic oncology Year: 2019 Management of malignant pleural effusions Source: Guideline 2001 Year: 2001